179 related articles for article (PubMed ID: 6184569)
1. Verapamil compared with nifedipine in the treatment of essential hypertension.
Midtbø K; Hals O; van der Meer J
J Cardiovasc Pharmacol; 1982; 4 Suppl 3():S363-8. PubMed ID: 6184569
[TBL] [Abstract][Full Text] [Related]
2. A comparison of amlodipine, verapamil and placebo in the treatment of mild to moderate hypertension. Amlodipine Study Group.
Lorimer AR; Smedsrud T; Walker P; Tyler HM
J Hum Hypertens; 1989 Jun; 3(3):191-6. PubMed ID: 2527993
[TBL] [Abstract][Full Text] [Related]
3. Slow channel inhibitors verapamil and nifedipine in the management of hypertension.
Gould BA; Hornung RS; Mann S; Balasubramanian V; Raftery EB
J Cardiovasc Pharmacol; 1982; 4 Suppl 3():S369-73. PubMed ID: 6184570
[TBL] [Abstract][Full Text] [Related]
4. [Controlled study on the treatment of hypertension with verapamil in retard form].
Belz GG; Spies G
Z Kardiol; 1985 Aug; 74(8):453-9. PubMed ID: 3901562
[TBL] [Abstract][Full Text] [Related]
5. Lisinopril versus slow release nifedipine in patients with essential hypertension: a multicentre study.
Predel HG; Kramer HJ
J Hum Hypertens; 1994 Oct; 8(10):777-80. PubMed ID: 7837215
[TBL] [Abstract][Full Text] [Related]
6. Conversion from sustained-release to immediate-release calcium entry blockers: outcome in patients with mild-to-moderate hypertension.
Hilleman DE; Mohiuddin SM; Lucas BD; Shinn B; Elsasser GN
Clin Ther; 1993; 15(6):1002-10. PubMed ID: 8111798
[TBL] [Abstract][Full Text] [Related]
7. Effects of nilvadipine and amlodipine in patients with mild to moderate essential hypertension: a double blind, prospective, randomised clinical trial.
Leonetti G;
Curr Med Res Opin; 2005 Jun; 21(6):951-8. PubMed ID: 15969895
[TBL] [Abstract][Full Text] [Related]
8. Multicentric, clinical trial of S-Amlodipine 2.5 mg versus Amlodipine 5 mg in the treatment of mild to moderate hypertension--a randomized, double-blind clinical trial.
Pathak L; Hiremath ; Kerkar PG; Manade VG
J Assoc Physicians India; 2004 Mar; 52():197-202. PubMed ID: 15636308
[TBL] [Abstract][Full Text] [Related]
9. [Hypotensive properties of nisoldipine. Comparative study in essential, renal and renovascular hypertension].
Wambach G; Breuer G; Kaufmann W
Arzneimittelforschung; 1984; 34(5):620-3. PubMed ID: 6540581
[TBL] [Abstract][Full Text] [Related]
10. Treatment of mild-to-moderate hypertension with calcium channel blockers: a multicentre comparison of once-daily nifedipine GITS with once-daily amlodipine.
Kes S; Caglar N; Canberk A; Deger N; Demirtas M; Dortlemez H; Kiliccioglu B; Kozan O; Ovunc K; Turkoglu C
Curr Med Res Opin; 2003; 19(3):226-37. PubMed ID: 12803737
[TBL] [Abstract][Full Text] [Related]
11. Comparisons of verapamil administration twice and three times daily in hypertension.
Salmela PI; Gordin A; Salo H; Ottoila P; Jounela AJ
Ann Clin Res; 1988; 20(3):195-200. PubMed ID: 3058014
[TBL] [Abstract][Full Text] [Related]
12. [Evaluation of the antihypertensive efficacy and safety of using sustained release verapamil in elderly subjects using ambulatory blood pressure monitoring].
Jasiński T; Janicki K; Klima M; Pieniazek W; Bednarz S
Przegl Lek; 1996; 53(2):73-7. PubMed ID: 8754325
[TBL] [Abstract][Full Text] [Related]
13. The effects of nonsteroidal anti-inflammatory drugs on blood pressures of patients with hypertension controlled by verapamil.
Houston MC; Weir M; Gray J; Ginsberg D; Szeto C; Kaihlenen PM; Sugimoto D; Runde M; Lefkowitz M
Arch Intern Med; 1995 May; 155(10):1049-54. PubMed ID: 7748048
[TBL] [Abstract][Full Text] [Related]
14. Calcium channel blocking drugs in the management of drug dependence, withdrawal and craving. A clinical pilot study with nifedipine and verapamil.
Shulman A; Jagoda J; Laycock G; Kelly H
Aust Fam Physician; 1998 Jan; 27 Suppl 1():S19-24. PubMed ID: 9503731
[TBL] [Abstract][Full Text] [Related]
15. Treatment of hypertension associated with stable angina pectoris: favourable interaction between new metoprolol formulation (OROS) and nifedipine.
Di Somma S; de Divitiis M; Bertocchi F; Carotenuto A; Cudemo G; Petitto M; Napodano M; de Divitiis O
Cardiologia; 1996 Jul; 41(7):635-43. PubMed ID: 8831181
[TBL] [Abstract][Full Text] [Related]
16. Bisoprolol and nifedipine SR in the treatment of hypertension in the elderly.
Oliván Martinez J; Garcia MJ; Rodriguez Botaro A; Pizarro JL; Carretero J; Garrido M
J Cardiovasc Pharmacol; 1990; 16 Suppl 5():S95-9. PubMed ID: 11527144
[TBL] [Abstract][Full Text] [Related]
17. Results of a phase III, 8-week, multicenter, prospective, randomized, double-blind, parallel-group clinical trial to assess the effects of amlodipine camsylate versus amlodipine besylate in Korean adults with mild to moderate hypertension.
Kim SH; Kim YD; Lim DS; Yoon MH; Ahn YK; On YK; Lee JW; Kim IJ; Park JB; Kim JJ; Chung WS; Yang JY; Seo HS; Shin EK; Kim HS;
Clin Ther; 2007 Sep; 29(9):1924-36. PubMed ID: 18035192
[TBL] [Abstract][Full Text] [Related]
18. Antihypertensive therapy with the long-acting calcium antagonist nitrendipine.
Müller FB; Bolli P; Erne P; Block LH; Kiowski W; Bühler FR
J Cardiovasc Pharmacol; 1984; 6 Suppl 7():S1073-6. PubMed ID: 6085370
[TBL] [Abstract][Full Text] [Related]
19. Haemodynamics, cardiac conduction and pharmacokinetics of mibefradil (Ro 40-5967), a novel calcium antagonist.
Petrie JR; Glen SK; MacMahon M; Crome R; Meredith PA; Elliott HL; Reid JL
J Hypertens; 1995 Dec; 13(12 Pt 2):1842-6. PubMed ID: 8903664
[TBL] [Abstract][Full Text] [Related]
20. The combination of verapamil and captopril in the treatment of essential hypertension.
Heagerty AM; Swales JD
Pharmatherapeutica; 1987; 5(1):21-5. PubMed ID: 3299395
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
